betatrophin hormone therapy (Evotec)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebetatrophin hormone therapy (Evotec)

Drug Alias Namebeta cell replication-supporting therapy (Evotec)beta cell replication-supporting therapy (Evotec/Janssen)betatrophin hormone therapy (Evotec/Janssen)CureBeta (Evotec)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionRegenerating islet-derived protein 3-alpha agonists

TargetsRegenerating islet-derived protein 3-alpha

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJanssen Pharmaceuticals Inc Harvard University Evotec SE

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A